Skip to main content
NCBI home page
Gut logoLink to Gut
. 2000 Apr;46(4):460–463. doi: 10.1136/gut.46.4.460

Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy

A Oksanen 1, P Sipponen 1, R Karttunen 1, A Miettinen 1, L Veijola 1, S Sarna 1, H Rautelin 1
PMCID: PMC1727900  PMID: 10716672

Abstract

BACKGROUND—Atrophic gastritis has been shown to be one of the long term sequelae of Helicobacter pylori infection.
AIMS—To determine the prevalence of atrophic gastritis in outpatients, to study the accuracy of serological methods for revealing atrophy, and to define the association of H pylori infection with atrophic gastritis in these patients.
PATIENTS/METHODS—A total of 207 consecutive outpatients referred for gastroscopy were included. Biopsy specimens from the antrum and corpus were assessed histologically according to the Sydney system. Serum samples were studied for H pylori IgG and IgA antibodies by enzyme immunoassay, CagA antibodies by immunoblot, pepsinogen I by an immunoenzymometric assay, gastrin by radioimmunoassay, and parietal cell antibodies by indirect immunofluorescence.
RESULTS—Histological examination revealed atrophic gastritis in 52 (25%) of 207 patients. H pylori and CagA antibodies were strongly associated with atrophic antral gastritis but poorly associated with atrophic corpus gastritis. Low serum pepsinogen I was the most sensitive and specific indicator of moderate and severe atrophic corpus gastritis. All six patients with moderate atrophic corpus gastritis had H pylori infection but eight of 10 patients with severe atrophic corpus had increased parietal cell antibodies and nine had no signs of H pylori infection.
CONCLUSIONS—Atrophic antral gastritis was strongly associated with CagA positive H pylori infection. Severe atrophic corpus gastritis was not determined by H pylori tests but low serum pepsinogen I, high gastrin, and parietal cell antibodies may be valuable in detecting these changes.


Keywords: Helicobacter pylori; atrophic gastritis; CagA antibodies; Helicobacter pylori antibodies; pepsinogen; parietal cell antibodies

Full Text

The Full Text of this article is available as a PDF (103.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995 May 15;55(10):2111–2115. [PubMed] [Google Scholar]
  2. Claeys D., Faller G., Appelmelk B. J., Negrini R., Kirchner T. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology. 1998 Aug;115(2):340–347. doi: 10.1016/s0016-5085(98)70200-8. [DOI] [PubMed] [Google Scholar]
  3. Cover T. L., Glupczynski Y., Lage A. P., Burette A., Tummuru M. K., Perez-Perez G. I., Blaser M. J. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995 Jun;33(6):1496–1500. doi: 10.1128/jcm.33.6.1496-1500.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crabtree J. E., Wyatt J. I., Sobala G. M., Miller G., Tompkins D. S., Primrose J. N., Morgan A. G. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993 Oct;34(10):1339–1343. doi: 10.1136/gut.34.10.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flejou J. F., Bahame P., Smith A. C., Stockbrugger R. W., Rode J., Price A. B. Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut. 1989 Jan;30(1):60–64. doi: 10.1136/gut.30.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fong T. L., Dooley C. P., Dehesa M., Cohen H., Carmel R., Fitzgibbons P. L., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology. 1991 Feb;100(2):328–332. doi: 10.1016/0016-5085(91)90199-u. [DOI] [PubMed] [Google Scholar]
  7. Haruma K., Komoto K., Kawaguchi H., Okamoto S., Yoshihara M., Sumii K., Kajiyama G. Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am J Gastroenterol. 1995 Jul;90(7):1107–1110. [PubMed] [Google Scholar]
  8. Karnes W. E., Jr, Samloff I. M., Siurala M., Kekki M., Sipponen P., Kim S. W., Walsh J. H. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991 Jul;101(1):167–174. doi: 10.1016/0016-5085(91)90474-y. [DOI] [PubMed] [Google Scholar]
  9. Kawaguchi H., Haruma K., Komoto K., Yoshihara M., Sumii K., Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol. 1996 May;91(5):959–962. [PubMed] [Google Scholar]
  10. Kekki M., Siurala M., Varis K., Sipponen P., Sistonen P., Nevanlinna H. R. Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl. 1987;141:1–28. [PubMed] [Google Scholar]
  11. Kosunen T. U., Seppälä K., Sarna S., Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992 Apr 11;339(8798):893–895. doi: 10.1016/0140-6736(92)90929-w. [DOI] [PubMed] [Google Scholar]
  12. Kuipers E. J., Klinkenberg-Knol E. C., Vandenbroucke-Grauls C. M., Appelmelk B. J., Schenk B. E., Meuwissen S. G. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl. 1997;223:28–34. [PubMed] [Google Scholar]
  13. Kuipers E. J., Pérez-Pérez G. I., Meuwissen S. G., Blaser M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995 Dec 6;87(23):1777–1780. doi: 10.1093/jnci/87.23.1777. [DOI] [PubMed] [Google Scholar]
  14. Kuipers E. J., Uyterlinde A. M., Peña A. S., Roosendaal R., Pals G., Nelis G. F., Festen H. P., Meuwissen S. G. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Jun 17;345(8964):1525–1528. doi: 10.1016/s0140-6736(95)91084-0. [DOI] [PubMed] [Google Scholar]
  15. Kurki R., Linder E., Miettinen A., Alfthan O., Heikkinen A., Pasternack A. Tissue antibodies in malignant and benign urogenital disease. Int J Cancer. 1977 Mar 15;19(3):332–336. doi: 10.1002/ijc.2910190308. [DOI] [PubMed] [Google Scholar]
  16. Ma J. Y., Borch K., Sjöstrand S. E., Janzon L., Mårdh S. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol. 1994 Nov;29(11):961–965. doi: 10.3109/00365529409094870. [DOI] [PubMed] [Google Scholar]
  17. Oksanen A., Veijola L., Sipponen P., Schauman K. O., Rautelin H. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol. 1998 Apr;36(4):955–957. doi: 10.1128/jcm.36.4.955-957.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Parsonnet J., Friedman G. D., Orentreich N., Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997 Mar;40(3):297–301. doi: 10.1136/gut.40.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
  20. Sozzi M., Valentini M., Figura N., De Paoli P., Tedeschi R. M., Gloghini A., Serraino D., Poletti M., Carbone A. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol. 1998 Mar;93(3):375–379. doi: 10.1111/j.1572-0241.1998.00375.x. [DOI] [PubMed] [Google Scholar]
  21. Strickland R. G., Mackay I. R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973 May;18(5):426–440. doi: 10.1007/BF01071995. [DOI] [PubMed] [Google Scholar]
  22. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  23. Varis K., Ihamäki T., Härkönen M., Samloff I. M., Siurala M. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol. 1979;14(2):129–139. doi: 10.3109/00365527909179858. [DOI] [PubMed] [Google Scholar]
  24. Varis K., Ihamäki T., Härkönen M., Samloff I. M., Siurala M. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol. 1979;14(2):129–139. doi: 10.3109/00365527909179858. [DOI] [PubMed] [Google Scholar]
  25. Varis K., Samloff I. M., Ihämaki T., Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci. 1979 Mar;24(3):187–191. doi: 10.1007/BF01308427. [DOI] [PubMed] [Google Scholar]
  26. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997 Oct;41(4):442–451. doi: 10.1136/gut.41.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES